- €21.12m
- €42.23m
- €39.58m
- 54
- 80
- 39
- 62
Annual balance sheet for Bio-UV SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 12.6 | 10.6 | 1.98 | 2.73 | 3.87 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.47 | 6.94 | 7.34 | 7.89 | 6.15 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 30.5 | 35 | 31 | 27.7 | 23.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.83 | 2.88 | 3.08 | 5.22 | 5.31 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 51.9 | 81.1 | 74.1 | 71.4 | 66.1 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.41 | 19 | 18.8 | 19.4 | 14.5 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 21.5 | 50.5 | 41.7 | 39.2 | 33.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 30.4 | 30.7 | 32.4 | 32.2 | 32.7 |
| Total Liabilities & Shareholders' Equity | 51.9 | 81.1 | 74.1 | 71.4 | 66.1 |
| Total Common Shares Outstanding |